IdentifAI Genetics Company
IdentifAI Genetics is developing a noninvasive prenatal test for the early detection of single-gene disorders. Using a simple first-trimester maternal blood test to access the entire embryonic genome, Identifai can perform a comprehensive analysis capable of detecting every single-point mutation, insertion-deletion, and structural variation in order to identify severe genetic disorders.
Headquarters:
Tel Aviv, Tel Aviv, Israel
Last Funding Date:
2021-12-01
Total Funding:
2450000
Last Funding Type:
Grant
Founded Date:
2020
Investors Number:
2
Industry:
Pregnancy, Maternal Health & Nursing
Employee Number:
1-10
Funding Status:
Seed